Innovus Pharmaceuticals got a dose of testosterone in its share price this week. The over-the-counter and consumer products for men’s and women’s health announced that it had recently acquired Beyond Human for a cash purchase price of $630,000. The acquisition provided the company with natural testosterone booster supplements, including Beyond T Human® and Human Growth … Continue reading “Innovus Pharmaceuticals (OTC: INNV) Grows Balls With Testosterone Supplement Acquisition”
Tag: Stock
Biotech & Pharma
Carbylan Therapeutics, Inc. (NASDAQ: CBYL) Suspends Hydros-TA Clinical Development
Carbylan Therapeutics announced in April that it has suspended further clinical development of its Hydros-TA.…
May 23, 2016
Biotech & Pharma
22nd Century Group, Inc. (NYSE: XXII) Launches New Line of Research Cigarettes
Shares of 22nd Century Group Inc. (NYSE: XXII) saw a bump in share price on…
May 23, 2016